SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-045797
Filing Date
2024-04-10
Accepted
2024-04-10 16:05:15
Documents
1
Period of Report
2024-04-08

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2411531-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2411531-1_4seq1.xml 4 4002
  Complete submission text file 0001104659-24-045797.txt   5542
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 9732420005
Synaptogenix, Inc. (Issuer) CIK: 0001571934 (see all company filings)

IRS No.: 461585656 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 780 THIRD AVENUE, 12TH FLOOR NEW YORK NY 10017
Business Address
Bernstein Bruce (Reporting) CIK: 0001665472 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40458 | Film No.: 24835781